Zinger Key Points
- ICBC Berlin 2025 will host 5,000+ cannabis leaders from 80+ countries, April 29–30. Save 25% on ICBC tickets with code Benzinga25.
- Germany’s cannabis market is booming with new laws, medical growth & homegrow demand.
- China’s new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for Matt Maley. Get the next trade alert free.
Europe’s largest cannabis B2B event is returning to Berlin in April 2025 as the International Cannabis Business Conference (ICBC) sets the stage for a landmark year in Germany’s rapidly evolving legal cannabis industry. Scheduled for April 29-30 at the Estrel Berlin Hotel, ICBC Berlin 2025 is expected to draw over 5,000 cannabis professionals from more than 80 countries, representing every major segment of the global cannabis supply chain.
Germany, now emerging as the most important cannabis market in Europe, has entered a transformative era. The country’s new CanG law, which came into effect on April 1, 2024, has already fueled exponential growth in medical cannabis prescriptions. Industry analysts estimate a tenfold increase in patient numbers over the past year. According to a Bloomwell Group report, prescriptions for medical cannabis grew by 1,000% between March and December 2024.
The removal of cannabis from Germany’s Narcotics List has been central to this surge, streamlining the prescribing process and boosting domestic production. While Germany's medical cannabis market was already Europe's largest before the reform, it's now expanding faster than ever. Zuanic & Associates projected that if only 1% of the population became cash-paying medical patients, the market could hit €1.7 billion by the end of 2025.
In tandem, the adult-use landscape is also shifting. As of July 2024, local regulators across Germany began accepting applications for cannabis cultivation associations, a key feature of the CanG law. Dozens of these associations have already launched, with North Rhine-Westphalia alone planning to approve up to 3,000. These groups will be pivotal in supplying cannabis genetics and products to consumers within the legal framework.
“Yes, I can imagine having my own cannabis to grow at home,” responded 51% of Germans in a recent Pronova BKK survey, underscoring rising public interest in home cultivation. With adults now allowed to grow up to three cannabis plants for personal use, companies supplying homegrow equipment and genetics are seeing a spike in demand. A YouGov survey found that 7% of Germans have already bought cannabis seeds or clones, while another 11% say they plan to.
This groundswell of interest is matched by strong momentum for regional adult-use commerce pilots, expected to launch soon. These pilots, combined with the growing number of cultivation associations, signal a fundamental reshaping of the cannabis landscape in Europe's most populous country.
ICBC Berlin 2025 offers a front-row seat to this historic evolution. New features this year include free VIP tickets for cannabis clinics and pharmacies, food and drink lounges, celebrity meet-and-greets, a speed networking area, treasure hunt activities, and a designated on-site consumption lounge.
For companies aiming to enter or expand within the European market, ICBC Berlin remains the most strategic venue to build connections, stay ahead of regulatory shifts, and access a highly targeted B2B audience. “It's the perfect place to put cannabis ideas on the global stage,” organizers say.
To encourage broader attendance, ICBC is offering a discount through its media partner Benzinga. By using the code Benzinga25, attendees will receive 25% off ticket prices. Registration is available via Eventbrite. Early registrants can also save an additional $200 if they purchase before midnight on April 2, 2025.
As competition intensifies across Europe's cannabis sector and as Germany's regulatory environment becomes a template for neighboring countries, ICBC Berlin 2025 is poised to be more than just a conference—it's a gateway to the future of global cannabis commerce.
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!